60 related articles for article (PubMed ID: 16553185)
21. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
[TBL] [Abstract][Full Text] [Related]
22. Cytological screening for precancerous lesions of the cervix.
Sng I
Singapore Med J; 1987 Oct; 28(5):415-21. PubMed ID: 3433107
[No Abstract] [Full Text] [Related]
23. Forty years of repeated screening: the significance of carcinoma in situ.
Morrison BJ; Coldman AJ; Boyes DA; Anderson GH
Br J Cancer; 1996 Sep; 74(5):814-9. PubMed ID: 8795587
[TBL] [Abstract][Full Text] [Related]
24. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
25. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
26. HPV testing and visual inspection for cervical cancer screening in resource-poor regions.
Jeronimo J; Castle PE; Herrero R; Burk RD; Schiffman M
Int J Gynaecol Obstet; 2003 Dec; 83(3):311-3. PubMed ID: 14643047
[No Abstract] [Full Text] [Related]
27. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
28. Cytologically diagnosed Gardnerella vaginalis infection and cervical (pre)neoplasia as established in population-based cervical screening.
Klomp JM; Boon ME; Van Haaften M; Heintz AP
Am J Obstet Gynecol; 2008 Nov; 199(5):480.e1-5. PubMed ID: 18565490
[TBL] [Abstract][Full Text] [Related]
29. Is it relevant to screen women younger than 26 years for precancerous and malignant cervical lesions ?
Ghosh A; Rao S; Pramanik T
Asian Pac J Cancer Prev; 2005; 6(2):123-4. PubMed ID: 16101318
[TBL] [Abstract][Full Text] [Related]
30. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
31. Screening for Cervical Cancer Among Low-Risk Populations: Orthodox Jewish Women as a Model.
Caspi R; Schejter E; Groutz A
J Womens Health (Larchmt); 2016 Jul; 25(7):747-51. PubMed ID: 26599257
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic human papilloma virus and cervical pre-cancerous lesions in brothel-based sex workers in India.
Sarkar K; Bhattacharya S; Bhattacharyya S; Chatterjee S; Mallick AH; Chakraborti S; Chatterjee D; Bal B
J Infect Public Health; 2008; 1(2):121-8. PubMed ID: 20701853
[TBL] [Abstract][Full Text] [Related]
34. Population-based prevalence of abnormal cervical cytology findings and local risk factors in Ibadan, Nigeria: implications for cervical cancer control programs and human papilloma virus immunization.
Thomas JO; Ojemakinde KO; Ajayi IO; Omigbodun AO; Fawole OI; Oladepo O
Acta Cytol; 2012; 56(3):251-8. PubMed ID: 22555526
[TBL] [Abstract][Full Text] [Related]
35. The natural history of Pap test screening in a rural population.
Rosenfeld JA
Tenn Med; 1998 May; 91(5):179-82. PubMed ID: 9584605
[No Abstract] [Full Text] [Related]
36. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
Martin-Hirsch P; Rash B; Martin A; Standaert B
BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
[TBL] [Abstract][Full Text] [Related]
37. The Cardiff Cervical Cytology Study: prevalence of cytological grades and initial histological findings.
Evans DM; Hibbard BM; Jones JM; Sweetnam P
Br Med J (Clin Res Ed); 1981 Feb; 282(6265):689-91. PubMed ID: 6781617
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
39. The effect of nonscreening smears on screening smear results: a statistical analysis with its implications for the NHS cervical screening programme.
Rice S; Slater DN; Hewer EM
Cytopathology; 2000 Jun; 11(3):158-65. PubMed ID: 10877275
[TBL] [Abstract][Full Text] [Related]
40. Quality improvement project in cervical cancer screening: practical measures for monitoring laboratory performance.
Tarkkanen J; Geagea A; Nieminen P; Anttila A
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):82-8. PubMed ID: 12580846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
